Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats

Circulation

Volumn 96, Issue 7, 1997, Pages 2317-2324

  Nossuli, Tareck O ^a   Hayward, Reid ^a   Scafia, Rosario ^a   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Endothelium; Endothelium derived factors; Ischemia; Leukocytes; Neutrophils; Reperfusion; Vasorelaxation

Indexed keywords

PEROXYNITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DRUG EFFECT; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030822473     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2317     Document Type: Article

References (54)

1. Färb A, Kolodgie FD, Jenkins M, Virmani R. Myocardial infarct extension during repcrfusion after coronary occlusion: pathological evidence. J Am Coll Cardiol. 1993;21:1245-1253.
2. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? 7 Clin Invest. 1985;76:1713-1719.
3. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402-1412.
4. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the rcperfused rat heart using electron spin resonance spcctroscopy. Ore Res. 19S7;61:757-760.
5. Arroyo CM, Kramer JH, Diskens BF, Weglicki WB. Identification of free radicals in myocardial ischemia/repcrfusion by spin trapping with nitrone DMPO. FEES Lett. 19S7;221:101-104.
6. Ambrosio G, Becker LC, Hutchens GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human Superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation. f9S6;74:1424-1433.
7. Werns SW, Simpson PJ, Mickelson JK, Shea MJ, Pitt B, Lucchesi BR. Sustained limitation by Superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J Carcliovasc Pharmacol.~19SS-,n:36-44.
8. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Client. 1996;271: 40-47.
9. Squadrito GL, Pryor WA. The formation of peroxynitrite in vivo from nitric oxide and Superoxide. Chem Biol Interact. 1995;96: 203-206.
10. Beckman JS, Crow JP. Pathological implications of nitric oxide, Superoxide and peroxynitrite formation. Biochem Soc Trans. 1992; 21:330-334.
11. Brunelli L, Crow JP, Beckman JS. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch Biochem Biophys. 1995;S16:327-334.
12. Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys. 1992;29S:452-457.
13. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of Superoxide and nitric oxide. J Biol Chem. 1991;266:4244-4250.
14. Ischiropoulos H, Al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEES Lett. 1995;364:279-282.
15. Lin KT, Xue JY, Nomen M, Spur B, Wong PYK. Peroxynitriteinduced apoptosis in HL-60 cells. J Biol Chem. 1995;270:1648716490.
16. Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Gollcr NL, Ohnishi ST, Laskin DL. Production of nitric oxide and peroxynitrite in the lung during acute cndotoxemia. J Leukocyte Biol. 1994;56:759-768.
17. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman B, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc NatlAcad Sei USA. 1994;91:1044-1048.
18. Szabo C, Salzman AL, Ischiropoulos H. Pcroxynitrite-mediatcd oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 1995;372:229-232.
19. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, Radomski MW, Moncada S. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc NatlAcad Sei USA. 1994;91:6702-6706.
20. Yin, K, Lai PS, Rodriguez A, Spur BW, Wong PYK. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets. Prostaglandins. 1995;50:169-178.
21. Ku DD, Liu S, Dai J. Coronary vascular and antiplatelet effects of peroxynitrite in human tissues. Endothelium. 1995;3:309-319.
22. Liu S, Beckman JS, Ku DD. Peroxynitrite, a product of Superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Etp Ther. 1993;268:1114-1121.
23. Wu M, Pritchard KA, Kaminski PM, Fayngersh RP, Hintze TH, Wolin MS. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol. 1994;266:H210S-H2113.
24. Lcfer DJ, Scalia R, Campbell B, Nossuli TO, Hayward R, Salamon M, Grayson J, Lefer AM. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. 7 din Invest. 1997;99:684-691.
25. Murohara T, Delyani JA, Albelda SM, Lefer AM. Blockade of platelet endothelial cell adherence molecule-l protects against myocardial ischemia and reperfusion injury in cats. J Imimmol. 1996;156:3550-3557.
26. Lafrado LJ, Oison RG. Demonstration of depressed polymorphonuclear leukocyte function in nonviremic Felv-infected cats. Cancer Invest. 19S6;4:297-300.
27. Yuan Y, Fleming BP. A method for isolation and fluorescent labeling of rat neutrophil for intravital microvascular studies. Microvasc Res. 1990;40:218-229.
28. Weyrich AS, Ma XI, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 1993; 91:2620-2629.
29. Weyrich AS, Buerke M, Albertine KH, Lefer AM. Time course of coronary vascular endothelial adherence molecule expression during reperfusion of the ischémie feline myocardium. J Leukoc Biol. 1995;57:45-55.
30. Beckman JS, Chen J, Iscbjropoulos H, Crow JP. Oxidative chemistry of peroxynitrite Methods Enzymol. 1994;233:229-240.
31. Ishida H, Ichimori K, Hirota Y, Fukahori M, Nakazawa H. Peroxynitrite-induced cardiac myocyte injury. Free Radie Biol Med. 1996;20:343-350.
32. Szabo C, Zingarelli B, Salzman AL. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous nitric oxide and peroxynitrite. Circ Res. 1996; 78:1051-1063.
33. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEES Lett. 1995;369:131-135.
34. Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate kinetics and influence on peroxynitrite-mediated oxidations. Arch Biocltem Biophys. 1996; 333:49-58.
35. Keim M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res. 1990;66:1561-1575.
36. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. Adv Enymol. 1992;65:287-346.
37. Wang P, Samouilov A, Kuppusamy P, Zweier J. Quantitation of Superoxide, nitric oxide and peroxynitrite generation in the postischemic heart. Circulation. 1996;94(suppl I):I-467. Abstract.
38. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Crueller CA. Mechanism of vascular smooth muscle relaxation by organic nitrites, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothioIs as active intermediates. J Phannacol Exp Tlier. 1981;218:739-749.
39. Moro MA, Darley-Usmar VM, Lizasoain I, Su Y, Knowles RG, Radomski MW, Moncada S. The formation of nitric oxide donors from peroxynitrite. Br J Phannacol. 1995;116:1999-2004.
40. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 1996:1239-1246.
41. Tarpey MM, Beckman JS, Ischiropoulos H, Gore JZ, Brock TA. Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis. FEES Lett. 1995;364:314-318.
42. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res. 1996;32:743-751.
43. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72: 403-412.
44. Entman ML, Smith CV. Postreperfusion inflammation: model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994; 28:1301-1311.
45. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastwenterology. 1994;107:1050-1058.
46. Gauthier TW, Scalia R,-Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyte-endothelial interactions in the early stages of hyperchoIesterolemia./lrtOTOsc/er Tliromb Vase Biol. 1995;15:1652-1659.
47. Pabla R, Buda AJ, Flynn DM, Blesse SA, Shin AM, Curtis MJ, Lefer DJ. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Cire Res. 1996;78:65-72.
48. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.y Phannacol Exp Hier.' 1992;260:668-675.
49. Johnson G III, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med. 1991:19:244-252.
50. DeCaterina R, Libby HB, Peng VJ, Thannickol TB, Rajavashisth MA, Gimbrone M, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: NO selectively reduces endothelial expression of adhesion molecules and proinfiammatory cytokines. / Clin Invest. 1995;95:2510-2519.
51. Entman ML, Youker K, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW. Neutrophil adherence to isolated adult canine myocytes. / Clin Invest. 1990;85:1497-1506.
52. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Plysiol. 1992;262:H616-H620.
53. Woolfson RB, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 1995;91:1545-1551.
54. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury. Cardiovasc Res. 1995:30:432-439.